Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0000950170-23-007901 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-14 | 2023-03-10 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | M - OptEx | $2.21 | +193.1K | 574.2K | +51% | +$426.7K |
| D | 2023-03-14 | 2023-03-10 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | M - OptEx | $0.00 | -193.1K | 1 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | M | A | 193,074 | $2.21 | 574,191 | D | — | — | (F2) Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-10 | M | D | 193,074 | $0.00 | 1 | D | $2.21 · — to 2027-06-22 | 193,074 Common Stock | (F3) The option is fully vested. |